A phase II study of 5-fluorouracil/L-leucovorin/oxaliplatin (mFOLFOX6) in Japanese patients with metastatic or unresectable small bowel adenocarcinoma

BACKGROUND: Several studies have suggested that chemotherapy prolonged survival in patients with metastatic or recurrent small bowel adenocarcinoma (SBA); however, there is still no standard chemotherapy regimen. Here, we evaluated the efficacy and safety of a 5-fluorouracil (5-FU)/L-leucovorin (l-L...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Int J Clin Oncol
Glavni autori: Horimatsu, Takahiro, Nakayama, Norisuke, Moriwaki, Toshikazu, Hirashima, Yoshinori, Fujita, Mikio, Asayama, Masako, Moriyama, Ichiro, Nakashima, Koji, Baba, Eishi, Kitamura, Hiroshi, Tamura, Takao, Hosokawa, Ayumu, Yoshimura, Kenichi, Muto, Manabu
Format: Artigo
Jezik:Inglês
Izdano: Springer Japan 2017
Teme:
Original Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5608770/
https://ncbi.nlm.nih.gov/pubmed/28536826
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10147-017-1138-6
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items